Literature DB >> 12543652

Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model.

Inga Odenholt1, Ingegerd Gustafsson, Elisabeth Löwdin, Otto Cars.   

Abstract

Optimizing pharmacokinetic/pharmacodynamic indices of antibiotics to obtain clinical and microbiological efficacy is essential, but dosing regimens must also be tailored to minimize the risk for emergence of resistance. The aim of the present study was to investigate whether certain concentrations of benzylpenicillin are critical for the selection of resistant subpopulations. A mixed culture of Streptococcus pneumoniae containing ca. 90% susceptible (MIC = 0.031 mg/liter), 9% intermediate (MIC = 0.25 mg/liter), and 1% resistant (MIC = 8 mg/liter) was studied in an in vitro kinetic model. The time that concentrations exceeded the MIC (T>MIC) for the three strains in the culture was varied by different initial concentrations of benzylpenicillin. Samples for viable counts were withdrawn at different times during 24 h and seeded on blood agar plates and on selective antibiotic-containing plates. The T>MIC varied from 46 to 100% for the susceptible strain, from 6 to 100% for the intermediate strain, and from 0 to 48% for the resistant strain. Our study, which may mimic the clinical situation with carriage of a mixed population of S. pneumoniae with different antibiotic susceptibilities, has shown that selection of resistant bacteria may easily occur if dosing regimens are only targeted toward fully susceptible strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543652      PMCID: PMC151721          DOI: 10.1128/AAC.47.2.518-523.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies.

Authors:  D Steinke; P Davey
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

Review 2.  Does the dose matter?

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

Review 3.  Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy.

Authors:  R Dagan; K P Klugman; W A Craig; F Baquero
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

4.  Antibiotic treatment in acute Otitis Media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment.

Authors:  R Dagan; E Leibovitz; G Cheletz; A Leiberman; N Porat
Journal:  J Infect Dis       Date:  2001-02-09       Impact factor: 5.226

5.  Antibiotic-resistant pneumococcal disease in South African children.

Authors:  I R Friedland; K P Klugman
Journal:  Am J Dis Child       Date:  1992-08

6.  Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model.

Authors:  I Gustafsson; E Löwdin; I Odenholt; O Cars
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations.

Authors:  M C Negri; M I Morosini; E Loza; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

8.  Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin.

Authors:  J D Knudsen; N Frimodt-Møller; F Espersen
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

9.  Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis.

Authors:  I R Friedland; K P Klugman
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

10.  Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

Authors:  R Pallares; J Liñares; M Vadillo; C Cabellos; F Manresa; P F Viladrich; R Martin; F Gudiol
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

View more
  14 in total

Review 1.  Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance.

Authors:  C Andrew DeRyke; Su Young Lee; Joseph L Kuti; David P Nicolau
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli.

Authors:  Sara K Olofsson; Patricia Geli; Dan I Andersson; Otto Cars
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Modeling the mechanism of postantibiotic effect and determining implications for dosing regimens.

Authors:  Patricia Geli
Journal:  J Math Biol       Date:  2009-02-03       Impact factor: 2.259

Review 4.  Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regimens that are less vulnerable to resistance.

Authors:  Chiara Adembri; Andrea Novelli
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.

Authors:  Peter Ankomah; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

6.  Extended Infusion β-Lactams for the Treatment of Gram-Negative Bacteremia in Children.

Authors:  Tracy N Zembles; Evelyn M Kuhn; Nathan E Thompson; Michelle L Mitchell
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

7.  In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.

Authors:  Lesley McGee; Donald Biek; Yigong Ge; Magderie Klugman; Mignon du Plessis; Anthony M Smith; Bernard Beall; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

8.  Continuous beta-lactam infusion in critically ill patients: the clinical evidence.

Authors:  Mohd H Abdul-Aziz; Joel M Dulhunty; Rinaldo Bellomo; Jeffrey Lipman; Jason A Roberts
Journal:  Ann Intensive Care       Date:  2012-08-16       Impact factor: 6.925

9.  Antimicrobial drug resistance, regulation, and research.

Authors:  Joshua P Metlay; John H Powers; Michael N Dudley; Keryn Christiansen; Roger G Finch
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

10.  Novel type of Streptococcus pneumoniae causing multidrug-resistant acute otitis media in children.

Authors:  Qingfu Xu; Michael E Pichichero; Janet R Casey; Mingtao Zeng
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.